Chemomab Therapeutics Ltd.

CMMB·NasdaqCM
Compare
1.3900+0.0100 (+0.72%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.3800
Open1.4600
Day range1.38101.4600
52-week range1.05103.5000
Off day high−4.79%
Off 52-week high−60.29%
Volume17.21K
Avg. volume (3M)110.79K
Market cap10.19M
EPS (TTM)-1.04
Forward P/E-46.33
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding7.33M
Short interest—
Earnings dateAug 19, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
CMMB EDSA AGMB FBLG BYSI CRIS
Market cap 10.19M 39.72M 447.66M 7.08M 25.31M 1.56M
P/E (TTM) — — — — — 0.5
Forward P/E -46.3 — -4.4 -0.3 -1.3 -0.1
Price/book 1.2 71.7 3.6 1.3 -0.7 0.3
Dividend yield — — — — — —
1-year change −58.93% +38.19% −37.95% −87.10% −64.56% −97.69%
Today +0.72% −16.24% +0.11% −11.50% +1.63% −4.16%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CMMB news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.